Fabrazyme

Product manufactured by Genzyme Corporation

Application Nr Approved Date Route Status External Links
BLA103979 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fabrazyme ® Is Indicated For Use In Patients With Fabry Disease. Fabrazyme Reduces Globotriaosylceramide (Gl-3) Deposition In Capillary Endothelium Of The Kidney And Certain Other Cell Types. Fabrazyme Is Indicated For Use In Patients With Fabry Disease. Fabrazyme Reduces Globotriaosylceramide (Gl-3) Deposition In Capillary Endothelium Of The Kidney And Certain Other Cell Types. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Agalsidase Beta

Comments